Monarch eTNS, a Bioelectronic Medical Device for Pediatric ADHD, Now Available
The device gained FDA approval in 2019 based on data from a placebo-controlled clinical trial that included 62 children with moderate to severe ADHD.
Attention-Deficit/Hyperactivity Disorder
Autism Among Top Factors for Likelihood of Bullying Exposure in Children
Researchers sought to investigate the factors that may modify the association between neurodevelopmental disorders and the risk for being bullied.
Updated Estimates of ADHD Prevalence, Comorbidity
Investigators extracted data from the Adolescent Behavior Cognition Development (ABCD) study, a longitudinal cohort study that enrolled children aged 9 to 10 years at baseline from 21 sites around the US.
Nonstimulant ADHD Treatment Option Approved for Adults
The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.
Physical Hand Features Possible Biomarkers of Mental Illness
An investigator at the University of Liverpool searched publication databases through 2020 for studies of dermatoglyphics, digit ratio, and palmar crease in conjunction with mental illness.
How Are Wearable Sensors and AI Technologies Being Used in Child Psychiatry Research?
Investigators from the Mayo Clinic searched publication databases with the goal of understanding how wearable devices were being used in child psychiatry research and how the understanding of pediatric psychiatric disorders has been enhanced by artificial intelligence technologies.
Behavior Management Training for Parents of Children With ADHD Underutilized
Authors analyzed the documentation of primary care professionals from electronic health records (EHRs) to find out the rate of PTBM recommendation for 4-5 year old patients with an ADHD diagnosis, ADHD symptoms or who were prescribed ADHD medication.
Can the Genetic Overlap of ADHD and Autism Guide Better Treatment?
Study researchers investigated the genetic overlap between ADHD and autism to determine if shared gene variants may provide insight into treatment targets.
Azstarys, a Novel ADHD Treatment, Now Available
Azstarys consists of serdexmethylphenidate, a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate.
Adhansia XR Labeling Updated With Additional Clinical Data
The sNDA approval was based on data from a phase 3 Adult Laboratory Classroom study that assessed the efficacy and safety of Adhansia XR in adults diagnosed with ADHD.
- Loading...
Loading...
Loading... 
Loading...